Enhanced Biostability of Nanoparticle-Based Drug Delivery Systems by Albumin Corona

References

• Weissleder R , KellyK , SunEY , ShtatlandT , JosephsonL . Cell-specific targeting of nanoparticles by multivalent attachment of small molecules . Nat. Biotechnol.23 ( 11 ), 1418 – 1423 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA , McNeilSE . Immunological properties of engineered nanomaterials . Nat. Nanotechnol.2 ( 8 ), 469 – 478 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Ryu JH , KooH , SunICet al. Tumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapy . Adv. Drug Deliv. Rev.64 ( 13 ), 1447 – 1458 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Donaldson K , DuffinR , LangrishJPet al. Nanoparticles and the cardiovascular system: a critical review . Nanomedicine (Lond.)8 ( 3 ), 403 – 423 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Petros RA , DesimoneJM . Strategies in the design of nanoparticles for therapeutic applications . Nat. Rev. Drug Discov.9 ( 8 ), 615 – 627 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Janib SM , MosesAS , MacKayJA . Imaging and drug delivery using theranostic nanoparticles . Adv. Drug Deliv. Rev.62 ( 11 ), 1052 – 1063 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Peng Q , ZhangZR , GongT , ChenGQ , SunX . A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles . Biomaterials33 ( 5 ), 1583 – 1588 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lalatsa A , LeeV , MalkinsonJP , ZlohM , SchatzleinAG , UchegbuIF . A prodrug nanoparticle approach for the oral delivery of a hydrophilic peptide, leucine(5)-enkephalin, to the brain . Mol. Pharm.9 ( 6 ), 1665 – 1680 ( 2012 ).
   PubMedGoogle Scholar
• Meyers JD , DoaneT , BurdaC , BasilionJP . Nanoparticles for imaging and treating brain cancer . Nanomedicine (Lond.)8 ( 1 ), 123 – 143 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Peng Q , SunX , GongTet al. Injectable and biodegradable thermosensitive hydrogels loaded with PHBHHx nanoparticles for the sustained and controlled release of insulin . Acta Biomater.9 ( 2 ), 5063 – 5069 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Uskokovic V . Entering the era of nanoscience: time to be so small . J. Biomed. Nanotechnol.9 ( 9 ), 1441 – 1470 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Paradise J , DilibertoGM , TisdaleAW , KokkoliE . Exploring emerging nanobiotechnology drugs and medical devices . Food Drug Law J.63 ( 2 ), 407 – 420 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Schutz CA , Juillerat-JeanneretL , MuellerH , LynchI , RiedikerM , NanoimpactnetC . Therapeutic nanoparticles in clinics and under clinical evaluation . Nanomedicine (Lond.)8 ( 3 ), 449 – 467 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yildirimer L , ThanhNT , LoizidouM , SeifalianAM . Toxicology and clinical potential of nanoparticles . Nano Today6 ( 6 ), 585 – 607 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Clift MJ , BhattacharjeeS , BrownDM , StoneV . The effects of serum on the toxicity of manufactured nanoparticles . Toxicol. Lett.198 ( 3 ), 358 – 365 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Perry JL , ReuterKG , KaiMPet al. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics . Nano Lett.12 ( 10 ), 5304 – 5310 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ehrenberg MS , FriedmanAE , FinkelsteinJN , OberdorsterG , McgrathJL . The influence of protein adsorption on nanoparticle association with cultured endothelial cells . Biomaterials30 ( 4 ), 603 – 610 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Cedervall T , LynchI , FoyMet al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles . Angew. Chem. Int. Ed. Engl.46 ( 30 ), 5754 – 5756 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Lundqvist M , StiglerJ , EliaG , LynchI , CedervallT , DawsonKA . Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts . Proc. Natl Acad. Sci. USA105 ( 38 ), 14265 – 14270 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Faunce TA , WhiteJ , MatthaeiKI . Integrated research into the nanoparticle–protein corona: a new focus for safe, sustainable and equitable development of nanomedicines . Nanomedicine (Lond.)3 ( 6 ), 859 – 866 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Lynch I , DawsonKA . Protein–nanoparticle interactions . Nano Today3 , 40 – 47 ( 2008 ).
   Web of Science ®Google Scholar
• Monopoli MP , AbergC , SalvatiA , DawsonKA . Biomolecular coronas provide the biological identity of nanosized materials . Nat. Nanotechnol.7 ( 12 ), 779 – 786 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kah JC , ChenJ , ZubietaA , Hamad-SchifferliK . Exploiting the protein corona around gold nanorods for loading and triggered release . ACS Nano6 ( 8 ), 6730 – 6740 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Walczyk D , BombelliFB , MonopoliMP , LynchI , DawsonKA . What the cell ‘sees’ in bionanoscience . J. Am. Chem. Soc.132 ( 16 ), 5761 – 5768 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Salvati A , AbergC , Dos SantosTet al. Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics . Nanomedicine7 ( 6 ), 818 – 826 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Lesniak A , SalvatiA , Santos-MartinezMJ , RadomskiMW , DawsonKA , AbergC . Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency . J. Am. Chem. Soc.135 ( 4 ), 1438 – 1444 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wang F , YuL , MonopoliMPet al. The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes . Nanomedicine9 ( 8 ), 1159 – 1168 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Rahman M , LaurentS , TawilN , YahiaL , MahmoudiM . Protein–nanoparticle interactions . Biophysics15 , 45 – 63 ( 2013 ).
   Google Scholar
• Ishida T , IchiharaM , WangX , KiwadaH . Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes . J. Control. Release115 ( 3 ), 243 – 250 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Knop K , HoogenboomR , FischerD , SchubertUS . Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives . Angew. Chem. Int. Ed. Engl.49 ( 36 ), 6288 – 6308 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Jokerst JV , LobovkinaT , ZareRN , GambhirSS . Nanoparticle PEGylation for imaging and therapy . Nanomedicine (Lond.)6 ( 4 ), 715 – 728 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Peng Q , ZhangS , YangQet al. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system . Biomaterials34 ( 33 ), 8521 – 8530 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Jeong H , HuhM , LeeSJet al. Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy . Theranostics1 , 230 – 239 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kratz F . Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles . J. Control. Release132 ( 3 ), 171 – 183 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Elsadek B , KratzF . Impact of albumin on drug delivery – new applications on the horizon . J. Control. Release157 ( 1 ), 4 – 28 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bhogale A , PatelN , MariamJ , DongrePM , MiotelloA , KothariDC . Comprehensive studies on the interaction of copper nanoparticles with bovine serum albumin using various spectroscopies . Colloids Surf. B Biointerfaces113 , 276 – 284 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Baek MS , YuRZ , GausH , GrundyJS , GearyRS . In vitro metabolic stabilities and metabolism of 2′-O-(methoxyethyl) partially modified phosphorothioate antisense oligonucleotides in preincubated rat or human whole liver homogenates . Oligonucleotides20 ( 6 ), 309 – 316 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Aggarwal P , HallJB , MclelandCB , DobrovolskaiaMA , McneilSE . Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy . Adv. Drug Deliv. Rev.61 ( 6 ), 428 – 437 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Bhogale A , PatelN , SarpotdarPet al. Systematic investigation on the interaction of bovine serum albumin with ZnO nanoparticles using fluorescence spectroscopy . Colloids Surf. B Biointerfaces102 , 257 – 264 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zhang X , LiL , XuZet al. Investigation of the interaction of naringin palmitate with bovine serum albumin: spectroscopic analysis and molecular docking . PLoS ONE8 ( 3 ), e59106 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kusonwiriyawong C , LipipunV , VardhanabhutiN , ZhangQ , RitthidejGC . Spray-dried chitosan microparticles for cellular delivery of an antigenic protein: physico-chemical properties and cellular uptake by dendritic cells and macrophages . Pharm. Res.30 ( 6 ), 1677 – 1697 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S , WangH , DucheyneP . Polymer-coated mesoporous silica nanoparticles for the controlled release of macromolecules . Acta Biomater.8 ( 9 ), 3429 – 3435 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zeng X , TaoW , MeiL , HuangL , TanC , FengSS . Cholic acid-functionalized nanoparticles of star-shaped PLGA–vitamin E TPGS copolymer for docetaxel delivery to cervical cancer . Biomaterials34 ( 25 ), 6058 – 6067 ( 2013 ).
   PubMed Web of Science ®Google Scholar